We’ve hit a major milestone here at Medtronic Diabetes. Today marks the first anniversary of the first shipment of our newest innovation, MiniMed 530G with Enlite!
Since we received FDA approval in September of 2013, thousands of people with diabetes have ordered the new MiniMed 530G system, which features Threshold Suspend technology that stops insulin delivery when your sensor glucose values reach a preset low threshold and are unable to respond to the Threshold Suspend alarm. It also includes the much anticipated Enlite sensor, approved to be worn for six days with improvements in comfort and accuracy.
So how has the product performed?
Looking at the last 12 months of CareLink uploads, Threshold Suspend has kicked in and suspended insulin delivery over 740,000 times. The events where insulin was suspended for the full two hours, 69% of them occurred during the nighttime.
But what are people saying?
We followed up with the first customer who received a MiniMed 530G system, Vince Myers, to see how things have gone over the last year. Here’s what he said:
“Since beginning with the MiniMed 530G with Enlite on October 16, 2013, I have experienced and maintained an A1c one full point lower than my previous averages. The MiniMed 530G with Enlite has provided me much more freedom and confidence to live life to the fullest through the consistent and accurate readings and delivery of insulin. Having my big brother on my hip has allowed me to reach my health goals while setting my sights on bigger and better challenges.”
Read his initial thoughts about the system here.
Here’s what other customers had to say about their experience using the new system:
“Overall, I found the new MiniMed 530G with Enlite came with a larger learning curve than I expected, but once I understood that and began moving along that curve, I really started to love my new system. And now, a few months in, I feel mostly back on auto-pilot again, and I’m happy to find the Enlite sensors are much more comfortable and accurate for me.” – Karen G.
“The MiniMed 530G insulin pump with continuous monitor has helped me in more ways than I could document.” – Bob B.
“I’ve been on the insulin pump for a little over 5 years now with great results after many years of 5 injections a day. Just this past January I started with the MiniMed 530G system with the Enlite sensor and like it a lot. I would never go back to multiple injections as this gives me so much control over what is happening.” – Shirley H.
“As a Bank Executive Officer, my schedule is generally filled with multiple daily meetings. The MiniMed 530G system allows me the flexibility of not having to schedule my meetings around meals or insulin injections, and also provides me with warning alerts of predicted high or low blood glucose levels.” – Mark K.
“The Enlite system/MiniMed 530G pump has been a Godsend for me!! I have hypoglycemia unawareness, and find myself trying to function with a 35 blood sugar – not good at work.” – Monica K.
“Since starting on the MiniMed 530G with Enlite, my diabetes has become easier to manage. The Enlite sensor and support from my start up team, who have worked with me in many areas, has helped me to stay in this target range. Additionally, I am now eating healthier, feeling better, and still determined to not let diabetes get the best of me.” – Kitty C.
We are thrilled to hear that the MiniMed 530G with Enlite is having such a positive impact for people with diabetes and we have appreciated all of your feedback shared this last year. We are committed to continuing to innovate and provide best-in-class technology that will transform diabetes care.
Note: Customer quotes were pulled from LOOP Blog comments and articles.
IMPORTANT SAFETY INFORMATION
Medtronic Diabetes insulin infusion pumps, continuous glucose monitoring systems and associated components are limited to sale by or on the order of a physician and should only be used under the direction of a healthcare professional familiar with the risks associated with the use of these systems. MiniMed 530G with Enlite is intended for the delivery of insulin and continuous glucose monitoring for the management of diabetes mellitus by persons 16 years of age or older who require insulin.
Pump therapy is not recommended for people who are unwilling or unable to perform a minimum of four blood glucose tests per day. Insulin pumps use rapid-acting insulin. If your insulin delivery is interrupted for any reason, you must be prepared to replace the missed insulin immediately.
The information provided by CGM systems is intended to supplement, not replace, blood glucose information obtained using a home glucose meter. A confirmatory fingerstick is required prior to making adjustments to diabetes therapy. MiniMed 530G with Enlite is not intended to be used directly for preventing or treating hypoglycemia but to suspend insulin delivery when the user is unable to respond to the Threshold Suspend alarm and take measures to prevent or treat hypoglycemia themselves.
Warning: The Threshold Suspend feature will cause the pump to temporarily suspend insulin delivery for two hours when the sensor glucose reaches a set threshold. Under some conditions of use the pump can suspend again resulting in very limited insulin delivery. Prolonged suspension can increase the risk of serious hyperglycemia, ketosis, and ketoacidosis. Before using the Threshold Suspend feature, it is important to read the Threshold Suspend information in the MiniMed 530G System User Guide and discuss proper use of the Threshold Suspend feature with your healthcare provider.
Please visit MedtronicDiabetes.com/isi for more details.
 Data from voluntary CareLink uploads available from October 15, 2013 to August 24, 2014 evaluated
, MiniMed 530G